This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
L. C. Baxter , R. J. Caselli , S. C. Johnson , E. Reiman , D. Osborne 2003. Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiology of Aging, 24, 947–952.
C. K. Blair 2005. APOE genotype and cognitive decline in a middle-aged cohort. Neurology, 64, 268–276.
P. Bretsky , J. M. Guralnik , L. Launer , M. Albert , T. E. Seeman 2003. The role of APOE-ε4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology, 60, 1077–1081.
R. Brookmeyer , S. Gray and C. Kawas 1998. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health, 88,1337–1342.
R. J. Caselli 1999. Preclinical memory decline in cognitively normal apolipoprotein E- ε4 homozygotes. Neurology, 53, 201–207.
R. M. Cohen , C. Small , F. Lalonde , J. Friz and T. Sunderland 2001. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology, 57, 2223–2228.
A. Collie 2001. Memory decline in healthy older people: implications for identifying mild cognitive impairment. Neurology, 56, 1533–1538.
E. H. Corder 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921–923.
E. H. Corder 1994 Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 180–184.
M. G. Dik , C. Jonker , L. M. Bouter , M. I. Geerlings , G. J. van Kamp and D. J. Deeg 2000. APOE-ε4 is associated with memory decline in cognitively impaired elderly. Neurology, 54, 1492–1497.
W. W. Eaton and L. G. Kessler 1985. Epidemiologic Field Methods in Psychiatry: The NIMH Epidemiologic Catchment Area Program. Orlando, FL: Academic Press.
W. W. Eaton 1997. Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Archives of General Psychiatry, 54, 993–999.
E. J. Feskens , L. M. Havekes , S. Kalmijn , P. de Knijff , L. J. Launer and D. Kromhout 1994. Apolipoprotein ε4 allele and cognitive decline in elderly men. BMJ, 309, 1202–1206.
G. G. Fillenbaum , L. R. Landerman , D. G. Blazer , A. M. Saunders , T. B. Harris and L. J. Launer 2001. The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. Journal of the American Geriatrics Society, 49, 1148–1155.
M. F. Folstein , S. E. Folstein and P. R. McHugh 1975. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
T. Gomez-Isla 1996 Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Annals of Neurology, 39, 62–70.
E. L. Helkala 1996 Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neuroscience Letters, 204, 177–180.
B. T. Hyman 1996. Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease. Journal of the American Geriatrics Society, 44, 1469–1471.
C. Jonker , B. Schmand , J. Lindeboom , L. M. Havekes and L. J. Launer 1998. Association between apolipoprotein E ε4 and the rate of cognitive decline in community dwelling elderly individuals with and without dementia. Archives of Neurology, 55, 1065–1069.
J. H. Kang , G. Logroscino , I. De Vivo , D. Hunter and F. Grodstein 2005. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiology of Aging, 26, 475–484.
A. S. Khachaturian , C. D. Corcoran , L. S. Mayer , P. P. Zandi and J. C. Breitner 2004. Cache County Study Investigators. Apolipoprotein E ε4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Archives of General Psychiatry, 61, 518–524.
L. Kuller 1998. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke, 29, 388–398.
C. Lahoz 2001. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis, 154, 529–537.
N. M. Laird and J. H. Ware 1982. Random-effects models for longitudinal data. Biometrics, 38, 963–974.
R. Mayeux , S. A. Small , M. Tang , B. Tycko and Y. Stern 2001. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. Neurobiology of Aging, 22, 683–689.
M. O. McCarron , D. Delong and M. J. Alberts 1999. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology, 53, 1308–1311.
E. L. Mortensen and P. Hogh 2001. A gender difference in the association between APOE genotype and age-related cognitive decline, Neurology, 57, 89–95.
R. O'Hara , J. A. Yesavage , H. C. Kraemer , M. Mauricio , L. F. Friedman and G. M. Jr. Murphy 1998 The APOE ε4 allele is associated with decline on delayed recall performance in community-dwelling older adults. Journal of the American Geriatrics Society, 46, 1493–1498.
T. G. Ohm , M. Kirca , J. Bohl , H. Scharnagl , W. Gross and W. Marz 1995. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience, 66, 583–587.
T. Pirttila 1997. Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains. Neurobiology of Aging, 18, 121–127.
T. Polvikoski 1995. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. The New England Journal of Medicine, 333, 1242–1247.
K. P. Riley , D. A. Snowdon , A. M. Saunders , A. D. Roses , J. A. Mortimer and N. Nanayakkara 2000 Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study. Journals of Gerontology Series B: Biological Sciences and Medical Sciences, 55, S69–S75.
L. N. Robins , J. E. Helzer , J. Croughan and K. Ratcliff 1981 National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Archives of General Psychiatry, 38, 381–389.
A. M. Saunders 1993. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467–1472.
D. L. Sparks 1997. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Annals of the New York Academy of Science, 826, 128–146.
J. H. Stengard , K. M. Weiss and C. F. Sing 1998. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Human Genetics, 103, 234–241.
P. H. George-Hyslop St. 2000. Genetic factors in the genesis of Alzheimer's disease. Annals of the New York Academy of Science, 924, 1–7.
C. Talbot , C. Lendon , N. Craddock , S. Shears , J.C. Morris and A. Goate 1994. Protection against Alzheimer's disease with apoE ε2. Lancet, 343, 1432–1433.
T. N. Tombaugh and N. J. McIntyre 1992. The mini-mental state examination: a comprehensive review. Journal of the American Geriatrics Society, 40, 922–935.
P. W. Wilson , E. J. Schaefer , M. G. Larson and J. M. Ordovas 1996. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 1250–1255.
R. S. Wilson 2002. The apolipoprotein ε 4 allele and decline in different cognitive systems during a 6-year period. Archives of Neurology, 59, 1154–1160.
M. Winnock , L. Letenneur , H. Jacqmin-Gadda , J. Dallongeville , P. Amouyel and J. F. Dartigues 2002. Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study. Journal of Neurology, Neurosurgery, and Psychiatry, 72, 794–797.
K. Yaffe , J. Cauley , L. Sands and W. Browner 1997. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Archives of Neurology, 54, 1110–1114.